Contract 75A50119C00055

Albert B. Sabin Vaccine Institute, Inc. (The) · Department Of Health And Human Services · September 26, 2019

Cost No FeeFull & Open CompetitionNAICS 541714

Albert B. Sabin Vaccine Institute, Inc. (The) was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on September 26, 2019 for $147.06 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Washington, DC. It was awarded under full and open competition. The contract has been modified 23 times since the base award It uses cost no fee contract pricing. The most recent modification was on May 6, 2025.

Obligated to date
$147.06M
$147,062,009
Current value
$147.06M
Potential value
$149.75M
if all options exercised
Modifications
23
Latest May 6, 2025

Contract details

PIID
75A50119C00055
Award type
Definitive Contract
Pricing
Cost No Fee
Set-aside
No Set Aside Used.
Competition
Full And Open Competition After Exclusion Of Sources
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
R&D- Medical: Specialized Medical Services (Advanced Development)
Place of performance
Washington, DC
First action
September 26, 2019
Latest action
May 6, 2025

Description

ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE.

Modification timeline

  • May 6, 2025
    Mod P00023
    $0
  • December 4, 2024
    Mod P00022
    $0
  • July 23, 2024
    Mod P00020
    $2.50M
  • May 21, 2024
    Mod P00019
    $776.6K
  • January 10, 2024
    Mod P00018
    $0
  • August 23, 2023
    Mod P00017
    $28.00M
  • May 4, 2023
    Mod P00016
    $0
  • February 14, 2023
    Mod P00014
    $799.0K
  • February 14, 2023
    Mod P00015
    $0
  • December 19, 2022
    Mod P00013
    $861.3K

Similar contracts

RecipientAgencyDateObligated
Vericel CorporationDepartment Of Health And Human ServicesApril 1, 2026$34.88M
Ceramedix Holding, LlcDepartment Of Health And Human ServicesMarch 31, 2026$4.22M
American College Of Medical Toxicology, Inc.Department Of Health And Human ServicesMarch 31, 2026$0
Glaxosmithkline, LlcDepartment Of Health And Human ServicesMarch 31, 2026$7.79M
Care Access Research LlcDepartment Of Health And Human ServicesMarch 31, 2026$2.55M
Pattern Bioscience, Inc.Department Of Health And Human ServicesMarch 31, 2026$22.50M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75A50119C00055?

Contract 75A50119C00055 is a federal contract awarded to Albert B. Sabin Vaccine Institute, Inc. (The) by Department Of Health And Human Services on September 26, 2019 for $147.06 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 23 times since the base award.

Who won contract 75A50119C00055?

Albert B. Sabin Vaccine Institute, Inc. (The) won contract 75A50119C00055 from Department Of Health And Human Services.

How much is contract 75A50119C00055 worth?

Contract 75A50119C00055 has obligated $147.06 million to date, with a total potential value of $149.75 million if all options are exercised.